NCT00348023View on ClinicalTrials.gov

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Glaucoma
Interventions
DRUG

Bimatoprost 0.03%, Travoprost 0.004%, Timolol 0.5%

Trial Locations (1)

15213

Dr. Noecker, Pittsburgh

Sponsors

Lead Sponsor

Innovative Medical
All Listed Sponsors
lead

Innovative Medical

INDUSTRY